FGC
MNTA

Financial Gravity Companies’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Financial Gravity Companies’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,457
Closed -$42K – 1731
2017
Q4 		$42K Buy
+2,457
New +$33.2K 0.05% 337

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Financial Gravity Companies's MNTA Position: Q1 2018 in Review

Financial Gravity Companies sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2018, closing a stake of 2,457 shares — an estimated $42K sold.

Financial Gravity Companies first reported a position in MNTA in Q4 2017 and held it in 1 quarter. The position peaked at $42K in Q4 2017. 163 funds tracked by Wall St. Rank hold MNTA as of Q1 2018.

  • Financial Gravity Companies reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Financial Gravity Companies sold 2,457 Momenta Pharmaceuticals, Inc. shares in Q1 2018, an estimated $42K.
  • Financial Gravity Companies first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • Financial Gravity Companies's Momenta Pharmaceuticals, Inc. position peaked at $42K in Q4 2017.
  • 163 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2018.

Based on Financial Gravity Companies's 13F filing for Q1 2018, filed 4 May 2018.